ENG/中
老虎证券
市场
行情
24/7新闻
产品
Cash Boost账户
期权
A股通
港股
固定票息票据
美股
ETF
基金超市
美国国债
新加坡股
期货
Tiger BOSS Debit Card
老虎钱袋子
功能
经纪人
定投
CPF/SRS 投资
专栏
美股碎股
TigerAI
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息（分红）
机构
Tiger Fund Management
机构服务
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
老虎API平台
登录
立即注册
Toggle
美股
详情
本页面由Tiger Trade Technology Pte. Ltd.提供服务
Filana Therapeutics
1.76
+0.1500
9.32%
盘前：
1.69
-0.0700
-3.98%
08:22 EDT
成交量：
99.12万
成交额：
168.92万
市值：
8,502.19万
市盈率：
-0.93
高：
1.77
开：
1.64
低：
1.58
收：
1.61
52周最高：
4.98
52周最低：
1.37
股本：
4,830.79万
流通股本：
4,347.52万
量比：
2.80
换手率：
2.28%
股息：
- -
股息率：
- -
每股收益(TTM):
-1.8836
每股收益(LYR):
-1.8836
净资产收益率：
-82.66%
总资产收益率：
-27.23%
市净率：
1.14
市盈率(LYR):
-0.93
数据加载中...
总览
公司
新闻资讯
公告
公司资料
公司名字：
Filana Therapeutics
交易所：
NASDAQ
成立时间：
1998
员工人数：
19
公司地址：
6801 N. Capital of Texas Highway,Building 1,Austin,Texas,United States
官网：
http://www.filanatx.com
邮编：
78731
电话：
512 501 2444
传真：
- -
简介：
Filana Therapeutics, Inc.于1998年5月在特拉华州注册成立。该公司是一家总部位于德克萨斯州奥斯汀的临床阶段生物技术公司。公司致力于开发变革性药物，以改善中枢神经系统疾病患者的生活，重点关注如结节性硬化症相关癫痫等与细丝蛋白A失调或过表达相关的疾病。其科学方法的核心在于调节大脑中这一关键蛋白质的活性。公司的主要在研治疗药物simufilam是一种口服的proprietary小分子药物，最初为阿尔茨海默病而开发。在阿尔茨海默病项目于2025年年中全面终止后，公司重新调整了工作重心。Simufilam目前正被研究用于治疗结节性硬化症相关癫痫，其靶点为细丝蛋白A——这是一种独立于传统mTOR通路的新型作用机制。临床前研究表明，这种潜在的首创型细丝蛋白A调节剂可能改善导致结节性硬化症患者癫痫发作的神经元过度生长和畸形。公司将继续探索simufilam在临床前实验显示可能具有疗效的其他潜在适应症，包括中枢神经系统相关及其他领域。
董事
名称
职位
Claude Nicaise
Chairman of the Board and Director
Richard J. Barry
Chief Executive Officer and Director and President
Dawn Carter Bir
Director
Michael J. O'donnell
Director
Patrick J. Scannon
Director
Pierre Gravier
Director
Robert Anderson
Director
Robert Z. Gussin
Director
股东
名称
职位
Richard J. Barry
Chief Executive Officer and Director and President
Eric J. Schoen
Chief Financial Officer
R. Christopher Cook
Chief Operating and Legal Officer
{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hans/stock/FLNA/company"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"FLNA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FLNA\",,,,,undefined,":{"symbol":"FLNA","market":"US","secType":"STK","nameCN":"Filana Therapeutics","latestPrice":1.76,"timestamp":1776369600000,"preClose":1.61,"halted":0,"volume":991206,"hourTrading":{"tag":"盘前","latestPrice":1.69,"preClose":1.76,"latestTime":"08:22 EDT","volume":413,"amount":721.9911125,"timestamp":1776428573954,"change":-0.07,"changeRate":-0.039773,"amplitude":0.051136},"delay":0,"changeRate":0.09316770186335398,"floatShares":43475193,"shares":48307896,"eps":-1.883615,"marketStatus":"盘前交易","change":0.15,"latestTime":"04-17 08:35:58 EDT","open":1.64,"high":1.77,"low":1.58,"amount":1689206.9214816,"amplitude":0.118012,"askPrice":1.78,"askSize":38,"bidPrice":1.69,"bidSize":6,"shortable":3,"etf":0,"ttmEps":-1.883615,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1776432600000},"marketStatusCode":1,"adr":0,"exchange":"NASDAQ","adjPreClose":1.76,"preHourTrading":{"tag":"盘前","latestPrice":1.69,"preClose":1.76,"latestTime":"08:22 EDT","volume":413,"amount":721.9911125,"timestamp":1776428573954,"change":-0.07,"changeRate":-0.039773,"amplitude":0.051136},"postHourTrading":{"tag":"盘后","latestPrice":1.75,"preClose":1.76,"latestTime":"19:58 EDT","volume":144946,"amount":255089.7897,"timestamp":1776383907945,"change":-0.01,"changeRate":-0.005682,"amplitude":0.028409},"volumeRatio":2.7966104555478544,"impliedVol":0.5379,"impliedVolPercentile":0.0385},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FLNA\",,,,,undefined,":{"symbol":"FLNA","floatShares":43475193,"roa":"-27.23%","roe":"-82.66%","lyrEps":-1.883615,"volumeRatio":2.7966104555478544,"shares":48307896,"dividePrice":0,"high":1.77,"amplitude":0.118012,"preClose":1.61,"low":1.58,"week52Low":1.37,"pbRate":"1.14","week52High":4.98,"institutionHeld":0.3447,"latestPrice":1.76,"committee":-0.727273,"eps":-1.883615,"divideRate":0,"volume":991206,"delay":0,"ttmEps":-1.883615,"open":1.64,"prevYearClose":1.98,"prevWeekClose":1.64,"prevMonthClose":1.69,"prevQuarterClose":1.69,"fiveDayClose":1.72,"twentyDayClose":1.91,"sixtyDayClose":1.99},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/FLNA\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-03-12","symbol":"FLNA","fiscalQuarterEnding":"2025/12","expectedEps":null,"name":null,"time":"盘前","type":"earning","dateTimestamp":1773288000000,"reportTimeType":"pre","actualEps":-0.26}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"FLNA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"FLNA\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":1,"updateTime":1759809600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/FLNA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"FLNA","date":"2026-04-15","current":-0.934374,"percent":1,"low":-1.062027,"twenty":-1.004677,"median":-0.929274,"eighty":-0.886793,"high":-0.844312,"avg":-0.942398,"sd":0.064318,"marketCap":76809554},"quantilePoints":[{"date":"2026-03-13","current":-1.035476,"twenty":-1.018822,"median":-0.993842,"eighty":-0.968861,"marketCap":94200397},{"date":"2026-03-20","current":-0.971755,"twenty":-1.052469,"median":-1.035476,"eighty":-0.980251,"marketCap":88403449},{"date":"2026-03-27","current":-0.939894,"twenty":-1.035476,"median":-0.99034,"eighty":-0.956117,"marketCap":85504975},{"date":"2026-04-02","current":-0.913343,"twenty":-1.035476,"median":-0.971755,"eighty":-0.913343,"marketCap":83089581},{"date":"2026-04-10","current":-0.913343,"twenty":-1.014236,"median":-0.950514,"eighty":-0.897413,"marketCap":83089581},{"date":"2026-04-15","current":-0.844312,"twenty":-1.004677,"median":-0.929274,"eighty":-0.886793,"marketCap":76809554}],"updateTime":1776404895233},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":107567,"yearFounded":1998,"employeeNum":19,"address":"6801 N. Capital of Texas Highway,Building 1,Austin,Texas,United States","zipCode":"78731","officePhone":"512 501 2444","fiscalYearEnd":"12-31"},"stockCompanyDetail":{"websiteUrl":"http://www.filanatx.com","stockEarnings":[{"period":"1week","weight":0.0233},{"period":"1month","weight":-0.12},{"period":"3month","weight":-0.1373},{"period":"6month","weight":-0.5907},{"period":"1year","weight":0.2571},{"period":"ytd","weight":-0.1111}],"compareEarnings":[{"period":"1week","weight":0.032},{"period":"1month","weight":0.046},{"period":"3month","weight":0.0145},{"period":"6month","weight":0.0561},{"period":"1year","weight":0.3348},{"period":"ytd","weight":0.0289}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Filana Therapeutics, Inc.于1998年5月在特拉华州注册成立。该公司是一家总部位于德克萨斯州奥斯汀的临床阶段生物技术公司。公司致力于开发变革性药物，以改善中枢神经系统疾病患者的生活，重点关注如结节性硬化症相关癫痫等与细丝蛋白A失调或过表达相关的疾病。其科学方法的核心在于调节大脑中这一关键蛋白质的活性。公司的主要在研治疗药物simufilam是一种口服的proprietary小分子药物，最初为阿尔茨海默病而开发。在阿尔茨海默病项目于2025年年中全面终止后，公司重新调整了工作重心。Simufilam目前正被研究用于治疗结节性硬化症相关癫痫，其靶点为细丝蛋白A——这是一种独立于传统mTOR通路的新型作用机制。临床前研究表明，这种潜在的首创型细丝蛋白A调节剂可能改善导致结节性硬化症患者癫痫发作的神经元过度生长和畸形。公司将继续探索simufilam在临床前实验显示可能具有疗效的其他潜在适应症，包括中枢神经系统相关及其他领域。","yearOnYearQuotes":[{"month":1,"riseRate":0.576923,"avgChangeRate":0.143985},{"month":2,"riseRate":0.461538,"avgChangeRate":0.031957},{"month":3,"riseRate":0.423077,"avgChangeRate":-0.001874},{"month":4,"riseRate":0.615385,"avgChangeRate":0.059045},{"month":5,"riseRate":0.44,"avgChangeRate":0.038503},{"month":6,"riseRate":0.44,"avgChangeRate":-0.019669},{"month":7,"riseRate":0.48,"avgChangeRate":0.007146},{"month":8,"riseRate":0.5,"avgChangeRate":0.01628},{"month":9,"riseRate":0.615385,"avgChangeRate":0.114687},{"month":10,"riseRate":0.423077,"avgChangeRate":-0.039373},{"month":11,"riseRate":0.576923,"avgChangeRate":-0.009282},{"month":12,"riseRate":0.346154,"avgChangeRate":0.016148}],"exchange":"NASDAQ","name":"Filana Therapeutics","nameEN":"Filana Therapeutics"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"FLNA\",market:\"US\",,,undefined,":{"directors":[{"name":"Claude Nicaise","position":"Chairman of the Board and Director"},{"name":"Richard J. Barry","position":"Chief Executive Officer and Director and President"},{"name":"Dawn Carter Bir","position":"Director"},{"name":"Michael J. O'donnell","position":"Director"},{"name":"Patrick J. Scannon","position":"Director"},{"name":"Pierre Gravier","position":"Director"},{"name":"Robert Anderson","position":"Director"},{"name":"Robert Z. Gussin","position":"Director"}],"executives":[{"name":"Richard J. Barry","position":"Chief Executive Officer and Director and President"},{"name":"Eric J. Schoen","position":"Chief Financial Officer"},{"name":"R. Christopher Cook","position":"Chief Operating and Legal Officer"}]}}}